- Home
- MLGO vs XBIT Comparison
MLGO vs XBIT Comparison
Compare MLGO & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLGO
- XBIT
- Stock Information
- Founded
- MLGO 2018
- XBIT 2005
- Country
- MLGO China
- XBIT United States
- Employees
- MLGO 87
- XBIT N/A
- Industry
- MLGO EDP Services
- XBIT Pharmaceuticals and Biotechnology
- Sector
- MLGO Technology
- XBIT Health Care
- Exchange
- MLGO Nasdaq
- XBIT Nasdaq
- Market Cap
- MLGO 101.1M
- XBIT 86.3M
- IPO Year
- MLGO N/A
- XBIT 2015
- Fundamental
- Price
- MLGO $9.06
- XBIT $2.90
- Analyst Decision
- MLGO
- XBIT
- Analyst Count
- MLGO 0
- XBIT 0
- Target Price
- MLGO N/A
- XBIT N/A
- AVG Volume (30 Days)
- MLGO 675.5K
- XBIT 41.6K
- Earning Date
- MLGO 09-18-2025
- XBIT 08-19-2025
- Dividend Yield
- MLGO N/A
- XBIT N/A
- EPS Growth
- MLGO N/A
- XBIT N/A
- EPS
- MLGO 16.40
- XBIT N/A
- Revenue
- MLGO $74,185,505.00
- XBIT N/A
- Revenue This Year
- MLGO N/A
- XBIT N/A
- Revenue Next Year
- MLGO N/A
- XBIT N/A
- P/E Ratio
- MLGO $0.56
- XBIT N/A
- Revenue Growth
- MLGO N/A
- XBIT N/A
- 52 Week Low
- MLGO $8.52
- XBIT $2.50
- 52 Week High
- MLGO $972.00
- XBIT $8.32
- Technical
- Relative Strength Index (RSI)
- MLGO 29.32
- XBIT 49.62
- Support Level
- MLGO $8.80
- XBIT $2.82
- Resistance Level
- MLGO $10.60
- XBIT $2.93
- Average True Range (ATR)
- MLGO 1.04
- XBIT 0.11
- MACD
- MLGO 0.93
- XBIT -0.00
- Stochastic Oscillator
- MLGO 5.74
- XBIT 28.21
About MLGO MicroAlgo Inc.
MicroAlgo Inc is divided into two segments: Central processing algorithm services & Intelligent chips and services. The majority is from the Central Processing Algorithm Services. which refers to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.